Synthesis and in vivo distribution in the rat of several fluorine-18 labeled 5-hydroxy-2-aminotetralin derivatives. 1993

S Zijlstra, and P H Elsinga, and E Z Oosterhuis, and G M Visser, and J Korf, and W Vaalburg
PET Center, University of Groningen, The Netherlands.

A method is described for the rapid production and purification of new potential dopamine agonists. Via thermal heating (refluxing in an oil bath) and microwave exposure 2-[N-n-3-fluoropropyl-N-(4-methylphenyl)ethylamino]-5-hydroxyte tralin (12), 2-[N-n-3-fluoropropyl-N-(4-fluorophenyl)ethylamino]-5-hydroxyte tralin (13), and their isotopic fluorine-18 derivatives were synthesized, respectively. The fluorine-18 label was introduced via N-fluoroalkylation with no-carrier-added (n.c.a.) 18FCH2CH2CH2I. In 115 min, radiochemical yields of 11% (corrected for decay) were achieved for both compounds. The specific activity ranged from 15-75 GBq/mumol. After i.v. injection in rats, the fluorine-18 labeled compounds were evaluated for their in vivo binding to the D2-receptors. The radioactivity levels in the striatum, nucleus accumbens and tuberculum olfactorius were not significantly higher than in the cerebellum and frontal cortex at 15, 30 and 60 min after administration of the tetralin derivatives. Dopamine depletion with reserpine did not affect the uptake in the dopamine D2-receptor rich area. Remarkable high uptakes were found in the adrenal for both compounds.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007553 Isotope Labeling Techniques for labeling a substance with a stable or radioactive isotope. It is not used for articles involving labeled substances unless the methods of labeling are substantively discussed. Tracers that may be labeled include chemical substances, cells, or microorganisms. Isotope Labeling, Stable,Isotope-Coded Affinity Tagging,Isotopically-Coded Affinity Tagging,Affinity Tagging, Isotope-Coded,Affinity Tagging, Isotopically-Coded,Isotope Coded Affinity Tagging,Labeling, Isotope,Labeling, Stable Isotope,Stable Isotope Labeling,Tagging, Isotope-Coded Affinity,Tagging, Isotopically-Coded Affinity
D008297 Male Males
D010627 Phenethylamines A group of compounds that are derivatives of beta- aminoethylbenzene which is structurally and pharmacologically related to amphetamine. (From Merck Index, 11th ed) Phenylethylamines
D005462 Fluorine Radioisotopes Unstable isotopes of fluorine that decay or disintegrate emitting radiation. F atoms with atomic weights 17, 18, and 20-22 are radioactive fluorine isotopes. Radioisotopes, Fluorine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013764 Tetrahydronaphthalenes Partially saturated 1,2,3,4-tetrahydronaphthalene compounds. Tetralins
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D017448 Receptors, Dopamine D2 A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D2-class receptor genes contain INTRONS, and the receptors inhibit ADENYLYL CYCLASES. Dopamine D2 Receptors,Dopamine-D2 Receptor,D2 Receptors, Dopamine,Dopamine D2 Receptor,Receptor, Dopamine-D2

Related Publications

S Zijlstra, and P H Elsinga, and E Z Oosterhuis, and G M Visser, and J Korf, and W Vaalburg
April 1993, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine,
S Zijlstra, and P H Elsinga, and E Z Oosterhuis, and G M Visser, and J Korf, and W Vaalburg
July 1980, Journal of medicinal chemistry,
S Zijlstra, and P H Elsinga, and E Z Oosterhuis, and G M Visser, and J Korf, and W Vaalburg
April 2023, Molecules (Basel, Switzerland),
S Zijlstra, and P H Elsinga, and E Z Oosterhuis, and G M Visser, and J Korf, and W Vaalburg
October 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
S Zijlstra, and P H Elsinga, and E Z Oosterhuis, and G M Visser, and J Korf, and W Vaalburg
April 1981, Archives internationales de pharmacodynamie et de therapie,
S Zijlstra, and P H Elsinga, and E Z Oosterhuis, and G M Visser, and J Korf, and W Vaalburg
March 2021, Molecular pharmaceutics,
S Zijlstra, and P H Elsinga, and E Z Oosterhuis, and G M Visser, and J Korf, and W Vaalburg
October 1977, Steroids,
S Zijlstra, and P H Elsinga, and E Z Oosterhuis, and G M Visser, and J Korf, and W Vaalburg
November 1994, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine,
S Zijlstra, and P H Elsinga, and E Z Oosterhuis, and G M Visser, and J Korf, and W Vaalburg
January 1994, Nuclear medicine and biology,
S Zijlstra, and P H Elsinga, and E Z Oosterhuis, and G M Visser, and J Korf, and W Vaalburg
November 2007, Seminars in nuclear medicine,
Copied contents to your clipboard!